Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Apr 18;21(5):728–736. doi: 10.1158/1055-9965.EPI-12-0023

Table 3.

Sensitivity analyses: Percent of disparities in CRC incidence and mortality between blacks and whites aged 50 years and older explained by screening and survival.

Sensitivity analysis CRC incidence disparity % explained by screening CRC mortality disparity
% explained by screening % explained by survival % explained by screening and survival*
Base case analysis 42% 19% 36% 54%
Lower-quality endoscopy in blacks 68% 34% 36% 66%
25% remaining survival difference 42% 19% 28% 46%
Same stage distribution as whites 42% 19% 57% 60%
*

Because of synergy in effects separate effects of screening and survival do not add up.